洁特生物: 关于2021年限制性股票激励计划首次授予部分第一个归属期的限制性股票第三次解除限售暨上市流通的公告

Core Viewpoint - The announcement details the third release of restricted stock from the 2021 stock incentive plan, with 44,822 shares set to be listed for trading on July 11, 2025, following a 36-month lock-up period since the vesting date of July 11, 2022 [1][2]. Group 1: Stock Incentive Plan Details - The total number of shares for this release is 44,822, representing 0.03% of the company's total share capital [8]. - The first category of incentive recipients will see 25% of their restricted shares released during this third unlock period [1][6]. - The company has previously completed two unlock phases for the same incentive plan, with 200,658 shares released on July 11, 2023, and 72,858 shares on July 12, 2024 [2][6]. Group 2: Share Capital Changes - Following the formation of the restricted shares, the company's total share capital increased by 60 shares due to the conversion of convertible bonds, resulting in a new total of 140,363,220 shares [3]. - The breakdown of shares before and after the release indicates that restricted shares decreased from 89,644 to 44,822, while unrestricted shares increased correspondingly [8]. Group 3: Compliance and Commitments - There are no special commitments from the shareholders of the restricted shares that would affect the listing and trading of these shares [6]. - The company confirms that there are no instances of fund occupation by controlling shareholders or related parties as of the announcement date [6].